Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeno Bisoffi

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
The Lancet. Global Health|August 9, 2014
When fever is not malariaZeno Bisoffi, Dora Buonfrate
Chest|May 9, 2021
Standard Dose Ivermectin for COVID-19Dora Buonfrate, Zeno Bisoffi
The Lancet. Infectious Diseases|April 2, 2021
Moxidectin: an ally to ivermectin for treating Strongyloides stercoralis?Zeno Bisoffi, Dora Buonfrate
The Journal of Infection|March 21, 2007
Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infectionMarina Boscolo, Zeno Bisoffi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Is Ivermectin Ineffective for Strongyloidiasis?Dora Buonfrate, Zeno Bisoffi
The Lancet. Infectious Diseases|May 21, 2016
Schistosomiasis transmission in EuropeZeno Bisoffi, Dora Buonfrate, Anna Beltrame
International Journal of Antimicrobial Agents|March 24, 2022
Reply to: Viral load reduction and high-dose ivermectin in early treatment: a reappraisalDora Buonfrate, Eliana Rulli, Zeno Bisoffi
BMJ (Clinical Research Ed.)|January 18, 2008
Costs of treating malaria according to test resultsZeno Bisoffi, Jef Van den Ende
Travel Medicine and Infectious Disease|December 17, 2013
Mefloquine restrictions, anti-malarial drug safety and the new Italian recommendations for malaria prophylaxisZeno Bisoffi, Federico Gobbi, Guido Calleri
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Comment on: Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literatureDora Buonfrate, Federico Gobbi, Zeno Bisoffi
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
The Lancet. Global Health|August 9, 2014
When fever is not malariaZeno Bisoffi, Dora Buonfrate
Chest|May 9, 2021
Standard Dose Ivermectin for COVID-19Dora Buonfrate, Zeno Bisoffi
The Lancet. Infectious Diseases|April 2, 2021
Moxidectin: an ally to ivermectin for treating Strongyloides stercoralis?Zeno Bisoffi, Dora Buonfrate
The Journal of Infection|March 21, 2007
Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infectionMarina Boscolo, Zeno Bisoffi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Is Ivermectin Ineffective for Strongyloidiasis?Dora Buonfrate, Zeno Bisoffi
The Lancet. Infectious Diseases|May 21, 2016
Schistosomiasis transmission in EuropeZeno Bisoffi, Dora Buonfrate, Anna Beltrame
International Journal of Antimicrobial Agents|March 24, 2022
Reply to: Viral load reduction and high-dose ivermectin in early treatment: a reappraisalDora Buonfrate, Eliana Rulli, Zeno Bisoffi
BMJ (Clinical Research Ed.)|January 18, 2008
Costs of treating malaria according to test resultsZeno Bisoffi, Jef Van den Ende
Travel Medicine and Infectious Disease|December 17, 2013
Mefloquine restrictions, anti-malarial drug safety and the new Italian recommendations for malaria prophylaxisZeno Bisoffi, Federico Gobbi, Guido Calleri
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Comment on: Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literatureDora Buonfrate, Federico Gobbi, Zeno Bisoffi
Pageof 22